AngioDynamics, Inc. Restructuring Charges
AngioDynamics, Inc. (ANGO) reported Restructuring Charges of $13.12 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-07-14
- AngioDynamics, Inc. restructuring charges for the quarter ending 2026-05-31 was $3.21M, a 65.28% increase year-over-year.
- AngioDynamics, Inc. restructuring charges for the quarter ending 2026-02-28 was $5.20M, a 65.97% increase year-over-year.
- AngioDynamics, Inc. restructuring charges for the quarter ending 2025-11-30 was $2.37M, a 53.53% decline year-over-year.
- AngioDynamics, Inc. restructuring charges for the quarter ending 2025-08-31 was $2.35M, a 34.66% decline year-over-year.
- AngioDynamics, Inc. restructuring charges for fiscal 2026 was $13.12M, a 4.67% decline from fiscal 2025.
- AngioDynamics, Inc. restructuring charges for fiscal 2025 was $13.76M.
- AngioDynamics, Inc. restructuring charges for fiscal 2020 was $26.00K, a 90.97% decline from fiscal 2019.
- AngioDynamics, Inc. restructuring charges for fiscal 2019 was $288.00K, a 93.84% decline from fiscal 2018.
| Period end | Restructuring Charges 0 month | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 6 month as first filed | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 10 month | Restructuring Charges 10 month as first filed | Restructuring Charges 12 month | Restructuring Charges 19 month | Restructuring Charges 22 month | Restructuring Charges 31 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $8.40M derived: sum of 2 quarters · filed 2026-07-14 | $10.77M derived: sum of 3 quarters · filed 2026-07-14 | $13.12M 10-K · filed 2026-07-14 | |||||||||
| 2026-02-28 | $5.20M 10-Q · filed 2026-04-02 | $7.57M derived: sum of 2 quarters · filed 2026-04-02 | $9.91M 10-Q · filed 2026-04-02 | $11.85M derived: sum of 4 quarters · filed 2026-04-02 | |||||||||
| 2025-11-30 | $2.37M 10-Q · filed 2026-01-06 | $4.72M 10-Q · filed 2026-01-06 | $6.66M derived: sum of 3 quarters · filed 2026-01-06 | $9.79M derived: sum of 4 quarters · filed 2026-01-06 | |||||||||
| 2025-08-31 | $2.35M 10-Q · filed 2025-10-02 | $4.29M derived: sum of 2 quarters · filed 2025-10-02 | $7.42M derived: sum of 3 quarters · filed 2025-10-02 | $12.52M derived: sum of 4 quarters · filed 2025-10-02 | |||||||||
| 2025-05-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $5.07M derived: sum of 2 quarters · filed 2025-07-18 | $10.17M derived: sum of 3 quarters · filed 2025-07-18 | $13.76M 10-K · filed 2025-07-18 | |||||||||
| 2025-02-28 | $3.13M 10-Q · filed 2025-04-02 | $8.23M derived: sum of 2 quarters · filed 2025-04-02 | $11.82M 10-Q · filed 2025-04-02 | $21.30M derived: sum of 4 quarters · filed 2025-04-02 | |||||||||
| 2024-11-30 | $5.10M 10-Q · filed 2025-01-08 | $8.69M 10-Q · filed 2025-01-08 | $18.17M derived: sum of 3 quarters · filed 2025-01-08 | $23.60M derived: sum of 4 quarters · filed 2025-01-08 | |||||||||
| 2024-08-31 | $3.59M 10-Q · filed 2024-10-03 | $13.07M derived: sum of 2 quarters · filed 2024-10-03 | $18.50M derived: sum of 3 quarters · filed 2024-10-03 | ||||||||||
| 2024-05-31 | $9.48M 10-K · filed 2024-07-25 | $14.91M derived: sum of 2 quarters · filed 2024-07-25 | |||||||||||
| 2024-02-29 | $5.43M 10-Q · filed 2024-04-09 | $6.12M 10-Q · filed 2024-04-09 | |||||||||||
| 2020-05-31 | $26.00K 10-K · filed 2020-08-10 | ||||||||||||
| 2019-08-31 | $100.00K 10-Q · filed 2019-10-04 | $122.00K derived: sum of 2 quarters · filed 2020-08-10 | $132.00K derived: sum of 3 quarters · filed 2020-08-10 | $260.00K derived: sum of 4 quarters · filed 2020-08-10 | $6.30M 10-Q · filed 2019-10-04 | ||||||||
| 2019-05-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $32.00K derived: sum of 2 quarters · filed 2020-08-10 | $160.00K derived: sum of 3 quarters · filed 2020-08-10 | $288.00K 10-K · filed 2020-08-10 | |||||||||
| 2019-02-28 | $10.00K 10-Q · filed 2019-04-02 | $138.00K derived: sum of 2 quarters · filed 2019-04-02 | $266.00K 10-Q · filed 2019-04-02 | $712.00K derived: sum of 4 quarters · filed 2020-08-10 | |||||||||
| 2018-11-30 | $128.00K 10-Q · filed 2019-01-07 | $258.00K 10-Q · filed 2019-01-07 | $702.00K derived: sum of 3 quarters · filed 2020-08-10 | $2.20M derived: sum of 4 quarters · filed 2020-08-10 | $6.20M 10-Q · filed 2019-04-02 | ||||||||
| 2018-08-31 | $100.00K 10-Q · filed 2019-10-04 | $130.00K 10-Q · filed 2018-10-01 | $574.00K derived: sum of 2 quarters · filed 2020-08-10 | $2.07M derived: sum of 3 quarters · filed 2020-08-10 | $3.47M derived: sum of 4 quarters · filed 2020-08-10 | $6.10M 10-Q · filed 2018-10-01 | |||||||
| 2018-05-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $1.97M derived: sum of 2 quarters · filed 2020-08-10 | $3.37M derived: sum of 3 quarters · filed 2020-08-10 | $4.67M 10-K · filed 2020-08-10 | |||||||||
| 2018-02-28 | $1.50M 10-Q · filed 2019-04-02 | $1.55M 10-Q · filed 2018-04-05 | $2.90M derived: sum of 2 quarters · filed 2019-04-02 | $4.20M 10-Q · filed 2019-04-02 | $4.18M 10-Q · filed 2018-04-05 | $5.25M derived: sum of 4 quarters · filed 2019-07-25 | |||||||
| 2017-11-30 | $1.40M 10-Q · filed 2019-01-07 | $1.42M 10-Q · filed 2018-01-05 | $2.60M 10-Q · filed 2019-01-07 | $2.64M 10-Q · filed 2018-01-05 | $3.75M derived: sum of 3 quarters · filed 2019-07-25 | $5.50M 10-Q · filed 2018-04-05 | $4.00M 10-Q · filed 2018-01-05 | $3.95M derived: sum of 4 quarters · filed 2019-07-25 | |||||
| 2017-08-31 | $1.20M 10-Q · filed 2018-10-01 | $1.22M 10-Q · filed 2017-09-29 | $2.35M derived: sum of 2 quarters · filed 2019-07-25 | $2.55M derived: sum of 3 quarters · filed 2019-07-25 | |||||||||
| 2017-05-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-25 | $1.35M derived: sum of 2 quarters · filed 2019-07-25 | $1.35M 10-K · filed 2019-07-25 | ||||||||||
| 2017-02-28 | $200.00K 10-Q · filed 2018-04-05 | $200.00K 10-Q · filed 2018-04-05 | |||||||||||
| 2016-05-31 | $0.00 10-Q · filed 2018-01-05 | ||||||||||||
| 2013-12-05 | $4.70M 10-Q · filed 2014-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |